Innovative Therapy Focus Sobi specializes in transforming the lives of patients with rare diseases through innovative therapies in haematology, immunology, and specialty indications, creating opportunities to introduce complementary treatments or advanced biologics that address similar niche markets.

Global Expansion With a workforce spanning Europe, North America, the Middle East, and Asia, Sobi’s international presence indicates potential for regional sales growth, partnerships, and tailored market strategies across diverse healthcare environments.

Supply Chain Modernization Recent partnerships with supply chain orchestration providers like Kinaxis suggest an emphasis on enhancing visibility and efficiency, offering a chance to engage in optimizing distribution networks or supporting scalable supply solutions.

Research & Clinical Engagements Sobi actively participates in major medical events and showcases extensive research, presenting opportunities to collaborate on clinical trials, research initiatives, or to provide complementary medical solutions aligned with their R&D focus.

Strategic Collaborations Partnerships with Ionis Pharmaceuticals for exclusive commercialization rights highlight Sobi’s openness to licensing and joint ventures, indicating potential for co-marketing collaborations, licensing deals, or expanding product portfolios within rare disease treatment spaces.